NCT01631305

Levothyroxine for Children With Euthyroid Sick Syndrome

Efficacy and Safety of Levothyroxine in Critical Children With Euthyroid Sick Syndrome in a Pediatric Intensive Care Unit.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: Sinaloa Pediatric Hospital · Academic / Other
• Sex: All
• Age: 1 Month – 17 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether levothyroxine is effective and safe in the treatment of children with euthyroid sick syndrome, hospitalized in a pediatric intensive care unit.

Detailed description

Children with euthyroid sick syndrome, hospitalized in a pediatric intensive care unit, will be randomised to receive either Levothyroxine or placebo, to determine if it diminishes mortality.

Conditions

• Euthyroid Sick Syndrome

Interventions

Type	Name	Description
DRUG	Levothyroxine	3 mcg/kg/day
OTHER	Calcium magnesia	Placebo.

Timeline

• Start date: 2012-01-01
• Primary completion: 2013-12-01
• Completion: 2013-12-01
• First posted: 2012-06-29
• Last updated: 2014-03-05

Locations

1 site across 1 country: Mexico